Nasus Pharma Ratios (2024-2025) | NSRX

Ratios Dec2024 Jun2025 Dec2025
Efficiency
Assets Average (Quarter) 0.68M2.82M
Equity Average (Quarter) -3.76M-0.77M
Invested Capital (Quarter) -1.41M-4.31M2.77M
Leverage & Solvency
Debt to Equity (Quarter) -0.56
Debt Ratio (Quarter) 2.51
Equity Ratio (Quarter) -4.48-6.750.55
Valuation
Enterprise Value (Quarter) -0.28M-0.23M-4.29M